Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
2023 | Bidding Procedure Approved for 9 Meters Biopharma, Inc. | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 16.32M 1.3B |
---|---|---|---|---|---|
Net income 2021 | -36M -2.87B | Net income 2022 | -43M -3.43B | EV / Sales 2021 | - |
Net cash position 2021 | 46.83M 3.74B | Net Debt 2022 | 7.08M 565M | EV / Sales 2022 | - |
P/E ratio 2021 |
-6.47
x | P/E ratio 2022 |
-0.37
x | Employees | 10 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.29% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | - | +-NaN% | 7 |
25/04/24 | - | +-NaN% | 5 |
23/04/24 | - | +-NaN% | 76 |
Delayed Quote OTC Markets, April 17, 2024 at 03:00 pm
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 14 | |
+137.37% | 5.68B | |
+1.89% | 1.01B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.27% | 819M | |
+1.68% | 663M | |
+0.54% | 610M | |
-.--% | 600M | |
+21.31% | 552M |
- Stock Market
- Equities
- NMTRQ Stock